These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16702391)

  • 1. No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.
    Agudo A; Sala N; Pera G; Capellá G; Berenguer A; García N; Palli D; Boeing H; Del Giudice G; Saieva C; Carneiro F; Berrino F; Sacerdote C; Tumino R; Panico S; Berglund G; Simán H; Stenling R; Hallmans G; Martínez C; Amiano P; Barricarte A; Navarro C; Quirós JR; Allen N; Key T; Bingham S; Khaw KT; Linseisen J; Nagel G; Overvad K; Tjonneland A; Olsen A; Bueno-de-Mesquita HB; Boshuizen HC; Peeters PH; Numans ME; Clavel-Chapelon F; Boutron-Ruault MC; Trichopoulou A; Lund E; Bläker H; Jenab M; Ferrari P; Norat T; Riboli E; González CA
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1043-5. PubMed ID: 16702391
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms of
    Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
    BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan.
    Wu MS; Chen CJ; Lin MT; Wang HP; Shun CT; Sheu JC; Lin JT
    Int J Colorectal Dis; 2002 Sep; 17(5):338-43. PubMed ID: 12172927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase (NAT1, NAT2) and glutathione S-transferase (GSTM1, GSTT1) polymorphisms in breast cancer.
    Lee KM; Park SK; Kim SU; Doll MA; Yoo KY; Ahn SH; Noh DY; Hirvonen A; Hein DW; Kang D
    Cancer Lett; 2003 Jul; 196(2):179-86. PubMed ID: 12860276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma.
    Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA
    Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of NAT2, CYP2E1 and GSTM1/GSTT1 polymorphisms with mild elevation of liver enzymes in Brazilian individuals under anti-tuberculosis drug therapy.
    Forestiero FJ; Cecon L; Hirata MH; de Melo FF; Cardoso RF; Cerda A; Hirata RD
    Clin Chim Acta; 2013 Jan; 415():215-9. PubMed ID: 23099118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of NAT2, CYP2E1, GST, and HLA related to drug-induced liver injury in indonesian tuberculosis patients.
    Perwitasari DA; Darmawan E; Mulyani UA; Vlies PV; Alffenaar JC; Atthobar J; Wilffert B
    Int J Mycobacteriol; 2018; 7(4):380-386. PubMed ID: 30531039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic interaction between NAT2, GSTM1, GSTT1, CYP2E1, and environmental factors is associated with adverse reactions to anti-tuberculosis drugs.
    Costa GN; Magno LA; Santana CV; Konstantinovas C; Saito ST; Machado M; Di Pietro G; Bastos-Rodrigues L; Miranda DM; De Marco LA; Romano-Silva MA; Rios-Santos F
    Mol Diagn Ther; 2012 Aug; 16(4):241-50. PubMed ID: 22788240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2.
    Godschalk RW; Dallinga JW; Wikman H; Risch A; Kleinjans JC; Bartsch H; Van Schooten FJ
    Pharmacogenetics; 2001 Jul; 11(5):389-98. PubMed ID: 11470992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
    Feng FM; Guo M; Chen Y; Li SM; Zhang P; Sun SF; Zhang GS
    Genet Mol Res; 2014 Nov; 13(4):9463-71. PubMed ID: 25501156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: a case-control study.
    Rodrigo L; Alvarez V; Rodriguez M; Pérez R; Alvarez R; Coto E
    Scand J Gastroenterol; 1999 Mar; 34(3):303-7. PubMed ID: 10232877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of NAT2, CYP2E1 and GST enzymes and the occurrence of antituberculosis drug-induced hepatitis in Brazilian TB patients.
    Teixeira RL; Morato RG; Cabello PH; Muniz LM; Moreira Ada S; Kritski AL; Mello FC; Suffys PN; Miranda AB; Santos AR
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):716-24. PubMed ID: 22012226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.
    Zgheib NK; Shamseddine AA; Geryess E; Tfayli A; Bazarbachi A; Salem Z; Shamseddine A; Taher A; El-Saghir NS
    Mutat Res; 2013; 747-748():40-7. PubMed ID: 23628324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.